GO:0006702 androgen biosynthetic process: Steroidogenic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006702 androgen biosynthetic process describes the chemical reactions and pathways that produce C19 steroid hormones capable of stimulating male sexual characteristics.
• The process occurs mainly in gonads, adrenal cortex, and peripheral tissues, and is driven by cytochrome P450 enzymes and hydroxysteroid dehydrogenases.
• Dysregulation of androgen biosynthesis underlies polycystic ovary syndrome (PCOS), idiopathic hirsutism, and androgen-secreting adrenal tumors.
• Key genes include CYP17A1, HSD3B2, HSD17B3, SRD5A2, and AKR1C3, which catalyze sequential conversions from cholesterol or adrenal precursors.
• Research models range from CRISPR knockout and point-mutation cell lines to overexpression systems for dissecting enzyme function.
• Understanding this pathway is essential for developing targeted therapies for androgen excess disorders and androgen-dependent cancers.
Description
Androgen biosynthetic process (GO:0006702) is the biological process that generates C19 steroid hormones, including testosterone, dihydrotestosterone (DHT), and androstenedione, which are critical for male sexual development and reproductive function. This process is not restricted to the gonads; the adrenal cortex and peripheral tissues also contribute to androgen production, particularly in pathological states such as polycystic ovary syndrome (PCOS) and idiopathic hirsutism. The pathway involves a series of enzymatic reactions that convert cholesterol or adrenal precursors into active androgens, with cytochrome P450 enzymes and hydroxysteroid dehydrogenases playing central roles. Researchers study this process to understand endocrine disorders, develop biomarkers for androgen excess, and design targeted therapies for conditions such as androgen-secreting tumors and PCOS. The QuickGO definition emphasizes the formation of androgens as C19 steroid hormones that stimulate male sexual characteristics, highlighting the pathway's specificity and physiological impact.
androgen biosynthetic process At A Glance
| GO ID | GO:0006702 |
|---|---|
| GO term | androgen biosynthetic process |
| Ontology | biological_process |
| Synonym | androgen anabolism, androgen biosynthesis, androgen formation, androgen synthesis |
| Major function | Production of C19 steroid hormones that stimulate male sexual characteristics |
| Major enzymes | CYP17A1, HSD3B2, HSD17B3, SRD5A2, AKR1C3 |
| Primary tissues | Gonads, adrenal cortex, peripheral tissues |
| Key precursors | Cholesterol, pregnenolone, DHEA, androstenedione |
| Associated diseases | PCOS, idiopathic hirsutism, androgen-secreting adrenal tumors |
What Is GO:0006702?
The androgen biosynthetic process (GO:0006702) encompasses the chemical reactions and pathways that result in the formation of androgens, which are C19 steroid hormones capable of stimulating the development of male sexual characteristics. This process includes the conversion of cholesterol or adrenal steroid precursors into testosterone, androstenedione, dehydroepiandrosterone (DHEA), and their active metabolites such as dihydrotestosterone (DHT). It is a multi-step enzymatic cascade involving cytochrome P450 enzymes, hydroxysteroid dehydrogenases, and reductases, and occurs primarily in the gonads, adrenal cortex, and peripheral tissues.
Why Is androgen biosynthetic process Important in Cell Biology?
Androgen biosynthetic process is fundamental to reproductive biology and endocrine health, as it governs the production of hormones that drive male sexual differentiation, spermatogenesis, and anabolic effects on muscle and bone. Dysregulation of this pathway leads to prevalent disorders such as polycystic ovary syndrome (PCOS), idiopathic hirsutism, and androgen-secreting adrenal tumors, which affect millions of women worldwide. Understanding the enzymatic steps and regulatory mechanisms of androgen biosynthesis is therefore critical for diagnosing and treating androgen excess conditions, as well as for developing therapies for androgen-dependent cancers.
• Androgens are essential for male sexual development and reproductive function.
• Dysregulated androgen biosynthesis is a hallmark of polycystic ovary syndrome (PCOS), a leading cause of infertility.
• Idiopathic hirsutism, affecting up to 10% of women, often involves increased androgen production or sensitivity.
• Androgen-secreting adrenal tumors can cause severe virilization and require surgical or pharmacological intervention.
• The pathway is a target for drugs used in prostate cancer and androgen excess disorders.
• Enzymes like CYP17A1 and HSD17B3 are biomarkers for adrenal and gonadal disorders.
• Research on androgen biosynthesis informs the development of contraceptives and hormone replacement therapies.
• CRISPR models of steroidogenic enzymes help dissect their specific roles in vivo.
• Understanding peripheral androgen synthesis is crucial for treating skin conditions like acne and hirsutism.
• The pathway intersects with metabolic regulation, linking androgens to insulin resistance and obesity.
What Happens During androgen biosynthetic process?
Initiation from Cholesterol or Adrenal Precursors
In simple terms: The body starts making androgens from cholesterol or from weaker hormones made by the adrenal glands.
Androgen biosynthesis begins with the conversion of cholesterol to pregnenolone by the cytochrome P450 side-chain cleavage enzyme (CYP11A1), primarily in the mitochondria of gonadal and adrenal cells. Alternatively, adrenal precursors such as DHEA and androstenedione can be converted to active androgens in peripheral tissues. This step is rate-limited by the availability of cholesterol and the activity of steroidogenic acute regulatory protein (StAR).
Conversion to Androstenedione and Testosterone
In simple terms: Enzymes then transform these precursors into testosterone and other active androgens.
Pregnenolone is converted to 17-hydroxypregnenolone by CYP17A1, then to DHEA via the lyase activity of CYP17A1. DHEA is subsequently converted to androstenedione by HSD3B2, and androstenedione is reduced to testosterone by HSD17B3 (in testes) or AKR1C3 (in peripheral tissues). These reactions are NADPH-dependent and occur in the smooth endoplasmic reticulum.
Activation to Dihydrotestosterone (DHT)
In simple terms: Testosterone can be further converted into a more potent androgen called DHT.
In target tissues such as the prostate and skin, testosterone is irreversibly converted to dihydrotestosterone (DHT) by the enzyme 5-alpha-reductase type 2 (SRD5A2). DHT binds to the androgen receptor with higher affinity than testosterone, amplifying androgenic effects. This step is crucial for male sexual differentiation and is implicated in androgenetic alopecia and prostate cancer.
Regulation by Gonadotropins and Local Factors
In simple terms: Hormones from the brain and local signals control how much androgen is made.
Luteinizing hormone (LH) from the pituitary stimulates testosterone production in Leydig cells, while adrenocorticotropic hormone (ACTH) regulates adrenal androgen synthesis. Local factors such as insulin and IGF-1 can enhance ovarian androgen production, contributing to PCOS. Negative feedback by androgens on the hypothalamus and pituitary maintains homeostasis.
Peripheral Conversion and Clearance
In simple terms: Androgens can be modified in other tissues and eventually broken down.
Peripheral tissues like adipose and skin express enzymes (e.g., AKR1C3, SRD5A1) that convert adrenal precursors to active androgens, contributing to local androgen excess in hirsutism. Androgens are eventually inactivated in the liver by conjugation and excreted. This peripheral pathway is a target for treating idiopathic hirsutism.
Key Genes Involved in GO:0006702 androgen biosynthetic process
The following genes encode key enzymes and regulatory proteins involved in the androgen biosynthetic process, with their roles and research relevance summarized.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP11A1 | Cholesterol side-chain cleavage to pregnenolone | Rate-limiting step; mutations cause adrenal hyperplasia |
| CYP17A1 | 17-alpha-hydroxylase and 17,20-lyase activities | Key branch point; mutations cause 17-alpha-hydroxylase deficiency |
| HSD3B2 | 3-beta-hydroxysteroid dehydrogenase | Converts DHEA to androstenedione; mutations cause adrenal hyperplasia |
| HSD17B3 | 17-beta-hydroxysteroid dehydrogenase type 3 | Converts androstenedione to testosterone; mutations cause 46,XY DSD |
| SRD5A2 | 5-alpha-reductase type 2 | Converts testosterone to DHT; mutations cause 5-alpha-reductase deficiency |
| AKR1C3 | Aldo-keto reductase family 1 member C3 | Peripheral conversion of androstenedione to testosterone |
| StAR | Steroidogenic acute regulatory protein | Cholesterol transport into mitochondria; mutations cause lipoid CAH |
| CYP21A2 | 21-hydroxylase | Adrenal steroidogenesis; mutations cause congenital adrenal hyperplasia |
| CYP19A1 | Aromatase | Converts androgens to estrogens; relevant to PCOS |
| AR | Androgen receptor | Mediates androgen action; mutations cause androgen insensitivity |
| SHBG | Sex hormone-binding globulin | Regulates free androgen levels; biomarker in PCOS |
| INS | Insulin | Stimulates ovarian androgen production; linked to PCOS |
| IGF1 | Insulin-like growth factor 1 | Enhances androgen synthesis in ovaries |
| LH | Luteinizing hormone | Stimulates Leydig cell testosterone production |
| ACTH | Adrenocorticotropic hormone | Regulates adrenal androgen synthesis |
| SRD5A1 | 5-alpha-reductase type 1 | Peripheral DHT production in skin |
| HSD11B1 | 11-beta-hydroxysteroid dehydrogenase type 1 | Local cortisol and androgen metabolism |
| CYP3A4 | Cytochrome P450 3A4 | Androgen catabolism in liver |
How Is androgen biosynthetic process Regulated?
Androgen biosynthetic process is tightly regulated by the hypothalamic-pituitary-gonadal (HPG) axis and the hypothalamic-pituitary-adrenal (HPA) axis. Luteinizing hormone (LH) pulses stimulate testosterone synthesis in Leydig cells, while ACTH regulates adrenal androgen production. Negative feedback by androgens and estrogens suppresses gonadotropin-releasing hormone (GnRH) and LH secretion. In PCOS, insulin resistance and hyperinsulinemia enhance ovarian androgen synthesis, and elevated LH/FSH ratios further drive androgen excess. Local growth factors such as IGF-1 and cytokines also modulate steroidogenic enzyme expression. Additionally, peripheral conversion by enzymes like SRD5A2 and AKR1C3 contributes to tissue-specific androgen action.
androgen biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP17A1 | PCOS, 17-alpha-hydroxylase deficiency | Knockout or point-mutation cell lines (e.g., HEK293) |
| HSD17B3 | 46,XY DSD, PCOS | Knock-in of mutant alleles in steroidogenic cells |
| SRD5A2 | 5-alpha-reductase deficiency, hirsutism | Overexpression in keratinocytes |
| AKR1C3 | PCOS, hirsutism | CRISPR knockout in ovarian theca cells |
| AR | Androgen insensitivity syndrome | Point-mutation knock-in in prostate cancer cells |
Polycystic Ovary Syndrome (PCOS)
PCOS is the most common endocrine disorder in women of reproductive age and is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Increased ovarian androgen biosynthesis, driven by insulin resistance and elevated LH, is a central feature. Elevated androgens contribute to hirsutism, acne, and metabolic complications. Research into CYP17A1, HSD17B3, and AKR1C3 has highlighted their roles in PCOS pathogenesis.
Idiopathic Hirsutism
Idiopathic hirsutism is defined as excessive male-pattern hair growth in women with normal ovulatory function and normal circulating androgen levels. However, many cases may involve increased peripheral sensitivity to androgens or enhanced local conversion of precursors to DHT by SRD5A1/2 and AKR1C3. The condition affects up to 10% of women and can significantly impact quality of life.
Androgen-Secreting Adrenal Tumors
Androgen-secreting adrenal tumors are rare but can cause severe virilization and hirsutism. They often overexpress steroidogenic enzymes such as CYP17A1 and HSD3B2, leading to excessive androgen production. Diagnosis involves measuring DHEA-S and testosterone, and treatment is primarily surgical.
Non-PCOS Hyperandrogenic Disorders in Adolescents
Adolescents may present with hyperandrogenic disorders other than PCOS, including congenital adrenal hyperplasia, Cushing syndrome, and androgen-secreting tumors. These conditions require careful biochemical evaluation to identify the specific enzymatic defects or tumors driving androgen excess.
From androgen biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CYP17A1 knockout reduce androgen production? | CRISPR knockout in H295R adrenal cells |
| How does HSD17B3 point mutation affect testosterone synthesis? | Point-mutation knock-in in Leydig cells |
| Can overexpression of SRD5A2 increase DHT in skin? | Overexpression in HaCaT keratinocytes |
| What is the role of AKR1C3 in peripheral androgen conversion? | Knockout in adipose stromal cells |
| Does tagged CYP11A1 localize to mitochondria? | Tagged knock-in in MA-10 Leydig cells |
| Can CRISPR library screening identify novel regulators of androgen synthesis? | Genome-wide knockout library in H295R cells |
How to Study the androgen biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Androgen concentrations | Quantifying testosterone and DHT in media |
| Enzyme activity assay | Conversion rates of substrates | Assessing mutant enzyme function |
| qRT-PCR | mRNA expression of steroidogenic genes | Validating CRISPR knockout effects |
| RNA-seq | Transcriptome changes | Identifying pathways altered by gene edits |
| Western blot | Protein expression and modification | Confirming knockout or overexpression |
| Immunofluorescence | Subcellular localization | Studying enzyme trafficking |
| CRISPR library screen | Genes affecting androgen production | Discovering novel regulators |
Steroid Hormone Quantification
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for measuring androgens such as testosterone, DHT, and androstenedione in cell culture media and serum. This method provides high sensitivity and specificity, enabling accurate assessment of enzymatic activity in CRISPR-edited cells.
Enzyme Activity Assays
In vitro enzyme assays using recombinant proteins or cell lysates can measure the conversion of radiolabeled or fluorescent substrates (e.g., androstenedione to testosterone) to assess the impact of genetic modifications on enzyme kinetics.
Gene Expression Analysis
Quantitative RT-PCR and RNA-seq are used to measure mRNA levels of steroidogenic enzymes (e.g., CYP17A1, HSD3B2) in response to CRISPR edits or hormonal stimulation. This helps link genotype to transcriptional regulation.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens in steroidogenic cell lines (e.g., H295R) can identify novel genes that regulate androgen biosynthesis. Hits are validated by targeted editing and hormone profiling.
How CRISPR Can Be Used to Study GO:0006702 androgen biosynthetic process
Knockout
CRISPR knockout of steroidogenic genes such as CYP17A1 or HSD17B3 in cell models (e.g., H295R, HEK293) abolishes enzyme activity, leading to reduced androgen production. These models are used to confirm the essential role of specific enzymes in the pathway and to study compensatory mechanisms.
Point Mutation
Point mutations identified in patients with disorders of sex development (DSD) or PCOS can be introduced into cell lines using CRISPR base editing or homology-directed repair. These models help determine whether a specific variant is pathogenic and how it affects enzyme kinetics.
Knock-in
Knock-in of tagged versions of enzymes (e.g., GFP-CYP11A1) allows real-time tracking of localization and interactions. Knock-in of mutant alleles can recapitulate disease phenotypes in vitro, providing a platform for drug testing.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like SRD5A2 or AKR1C3 can model androgen excess states. These systems are useful for studying the effects of increased enzyme activity on cell proliferation and gene expression.
How EDITGENE Supports androgen biosynthetic process Research
Researchers studying androgen biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in hormone production, how specific mutations affect enzyme function, and whether targeting the pathway can reverse disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for androgen biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SRD5A2 Knockout HEK293 Cell Line | EDJ-KQ1895 | Human | 6716 | Details Get a Quote |
| SRD5A1 Knockout HEK293 Cell Line | EDJ-KQ2660 | Human | 6715 | Details Get a Quote |
| HSD17B2 Knockout HEK293 Cell Line | EDJ-KQ4940 | Human | 3294 | Details Get a Quote |
| HSD3B2 Knockout HEK293 Cell Line | EDJ-KQ4948 | Human | 3284 | Details Get a Quote |
| HSD17B3 Knockout HEK293 Cell Line | EDJ-KQ4949 | Human | 3293 | Details Get a Quote |
| HSD17B6 Knockout HEK293 Cell Line | EDJ-KQ6305 | Human | 8630 | Details Get a Quote |
| HSD17B12 Knockout HEK293 Cell Line | EDJ-KQ10944 | Human | 51144 | Details Get a Quote |
| SRD5A3 Knockout HEK293 Cell Line | EDJ-KQ16792 | Human | 79644 | Details Get a Quote |
| CYP17A1 Knockout HEK293 Cell Line | EDJ-KQ17810 | Human | 1586 | Details Get a Quote |
| HSD17B6 Knockout A-549 Cell Line | EDJ-KQ30211 | Human | 8630 | Details Get a Quote |
| HSD17B6 Knockout HCT 116 Cell Line | EDJ-KQ30212 | Human | 8630 | Details Get a Quote |
| SRD5A1 Knockout A-549 Cell Line | EDJ-KQ23441 | Human | 6715 | Details Get a Quote |
| SRD5A1 Knockout HCT 116 Cell Line | EDJ-KQ23442 | Human | 6715 | Details Get a Quote |
| SRD5A1 Knockout HeLa Cell Line | EDJ-KQ23443 | Human | 6715 | Details Get a Quote |
| HSD17B12 Knockout A-549 Cell Line | EDJ-KQ38739 | Human | 51144 | Details Get a Quote |
Displaying Records 1 To 15 Of 41 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About androgen biosynthetic process
What is androgen biosynthetic process?
Androgen biosynthetic process (GO:0006702) is the biological pathway that produces C19 steroid hormones, such as testosterone and DHT, which stimulate male sexual characteristics.
What genes are involved in androgen biosynthetic process?
Key genes include CYP11A1, CYP17A1, HSD3B2, HSD17B3, SRD5A2, and AKR1C3, which encode enzymes catalyzing the steps from cholesterol to active androgens.
Which diseases are associated with defects in androgen biosynthesis?
Disorders include polycystic ovary syndrome (PCOS), idiopathic hirsutism, androgen-secreting adrenal tumors, and congenital adrenal hyperplasia.
How is androgen biosynthesis regulated?
It is regulated by LH and ACTH from the pituitary, as well as local factors like insulin and IGF-1, with negative feedback by androgens.
What is the role of CYP17A1 in androgen synthesis?
CYP17A1 catalyzes 17-alpha-hydroxylation and 17,20-lyase reactions, converting pregnenolone to DHEA and progesterone to androstenedione, a critical branch point.
Can CRISPR be used to study androgen biosynthetic process?
Yes, CRISPR knockout, point mutation, and overexpression models in steroidogenic cell lines allow functional dissection of enzymes and regulators.
What are the main tissues where androgen biosynthesis occurs?
Androgens are primarily produced in the gonads (testes, ovaries) and adrenal cortex, with peripheral conversion in skin and adipose tissue.
How is androgen excess diagnosed?
Diagnosis involves measuring serum androgens (testosterone, DHEA-S) and clinical assessment of hirsutism using the Ferriman-Gallwey score.
What is idiopathic hirsutism?
Idiopathic hirsutism is excessive hair growth in women with normal androgen levels, possibly due to increased peripheral sensitivity or local androgen conversion.
What research models are available for androgen biosynthesis?
Models include H295R adrenal cells, MA-10 Leydig cells, and CRISPR-edited cell lines for knockout, knock-in, and overexpression studies.
Conclusion
Androgen biosynthetic process (GO:0006702) is a central metabolic pathway with profound implications for reproductive health and disease. The enzymatic cascade from cholesterol to active androgens involves tightly regulated steps that are disrupted in common disorders like PCOS and hirsutism. Advances in CRISPR technology now enable precise modeling of these steps, offering new opportunities for therapeutic discovery. By leveraging EDITGENE's comprehensive gene editing services, researchers can accelerate the translation of basic findings into clinical solutions for androgen-related conditions.
References
- 1. Azziz R et al.. 2016. Polycystic ovary syndrome.. Nat Rev Dis Primers 2:16057 PMID: 27510637
- 2. Cussen L et al.. 2022. Approach to androgen excess in women: Clinical and biochemical insights.. Clin Endocrinol (Oxf) 97(2):174-186 PMID: 35349173
- 3. Azziz R et al.. 2000. Idiopathic hirsutism.. Endocr Rev 21(4):347-62 PMID: 10950156
- 4. Rittmaster RS. 1997. Hirsutism.. Lancet 349(9046):191-5 PMID: 9111556
- 5. de Kroon RWPM et al.. 2022. Is idiopathic hirsutism idiopathic?. Clin Chim Acta 531:17-24 PMID: 35292252
- 6. Yildiz BO et al.. 2010. Visually scoring hirsutism.. Hum Reprod Update 16(1):51-64 PMID: 19567450
- 7. Esquivel-Zuniga MR et al.. 2022. Non-PCOS Hyperandrogenic Disorders in Adolescents.. Semin Reprod Med 40(1-02):42-52 PMID: 35052005
- 8. Sciarra F et al.. 1995. Androgen-secreting adrenal tumors.. Minerva Endocrinol 20(1):63-8 PMID: 7651284
